Gesterol Gel 1.125gm

Gesterol Gel 1.125gm may interact with certain medicines that affect hormone metabolism or progesterone activity.

• Antitubercular medicines (Rifampicin): Rifampicin may increase liver enzyme activity, which can lower progesterone levels and reduce the therapeutic effect of hormonal support.
• Antiepileptic medicines (Carbamazepine, Phenytoin): These medicines may increase the metabolism of progesterone in the liver, potentially reducing its effectiveness in supporting the uterine lining during fertility treatment.
• Antifungal medicines (Ketoconazole): Some antifungal medicines may inhibit progesterone metabolism and increase progesterone levels in the body.
• Other hormonal medicines (Estrogen therapy or hormonal contraceptives): Concurrent use may alter hormonal balance and affect fertility treatment outcomes.
• Other vaginal medicines: Using multiple vaginal medicines together may affect the absorption or distribution of progesterone gel. Your doctor may advise spacing the use of different vaginal products.

Use Gesterol Gel 1.125gm with caution if you have:

• Thromboembolic disorders (blood clot conditions): Patients with a current or past history of conditions such as thrombophlebitis, pulmonary embolism, stroke, or other thromboembolic disorders should not use this medicine unless specifically advised by a doctor. Progesterone therapy may increase the risk of blood clot formation in susceptible individuals. If symptoms such as sudden leg swelling, chest pain, breathing difficulty, or vision changes occur during treatment, medical attention should be sought immediately.
• Hormone-dependent cancers: Patients with known or suspected cancers of the breast or reproductive organs that are sensitive to hormones should avoid progesterone therapy unless recommended by a specialist. Hormonal treatments may influence the growth of certain hormone-dependent tumours.
• Unexplained vaginal bleeding: This medicine should not be used in patients with undiagnosed vaginal bleeding. The underlying cause of the bleeding should be investigated before starting progesterone treatment to rule out serious conditions.
• Porphyria: Patients with porphyria, a rare inherited disorder affecting haem production, should not take progesterone therapy, as it may worsen the condition.

Use Gesterol Gel 1.125gm exactly as prescribed by your doctor. The treatment schedule usually begins during fertility procedures and may continue for a specific duration depending on treatment response and pregnancy status.

An overdose is unlikely because the medicine is supplied in pre-filled single-use applicators designed to deliver a controlled amount of gel. If excessive use occurs, consult your doctor for guidance.

If you forget to use Gesterol Gel 1.125gm, apply it as soon as you remember, unless it is close to the time for the next scheduled application. Do not apply extra medicine to make up for the missed dose.